|
|
"A comprehensive, collaborative elections resource."
|
“No choice at all”: Pharma companies begrudgingly agree to negotiate prices
|
|---|
| Parent(s) |
Issue
|
| Contributor | RP |
| Last Edited | RP Sep 29, 2023 02:51pm |
| Logged |
0
|
| Category | General |
| Author | Beth Mole |
| News Date | Friday, September 29, 2023 07:55:00 PM UTC0:0 |
| Description | At least four top pharmaceutical companies suing the federal government over a new requirement to negotiate Medicare drug prices have agreed to come to the table for the first round of negotiations—at least for now.
Further Reading
The 10 drugs up for Medicare price negotiation have seen steep price hikes
Merck, AstraZeneca, Bristol Myers Squibb, and Boehringer Ingelheim have all said that they will agree to the negotiations, though some were clearly bitter about it. |
| Share |
|
|
2¢
|
|
| Article | Read Full Article |
|
| Date |
Category |
Headline |
Article |
Contributor |
|
|
